Herbert Strobl

Herbert Strobl

Auto-generated profile, based on publicly available information

Herbert Strobl

Division of Immunology, Otto Loewi Research Center, Medical University of Graz, Graz, Austria

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 November 2013 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
NYNighat Yasmin
Nighat Yasmin
TBThomas Bauer
Thomas Bauer
MMMadhura Modak
Madhura Modak
KWKarin Wagner
Karin Wagner
CSChristopher Schuster
Christopher Schuster
HSHerbert Strobl
Herbert Strobl
Human Langerhans cell (LC) precursors populate the epidermis early during prenatal development and thereafter undergo massive proliferation. The prototypic antiproliferative cytokine TGF-β1 is required for LC differentiation from human CD34+ hematopoietic progenitor cells and blood monocytes in vitro. Similarly, TGF-β1 deficiency results in LC loss in vivo. However, immunohistology studies revealed that human LC niches in early prenatal epidermis and adult basal (germinal) keratinocyte layers lack detectable TGF-β1. Here we demonstrated that these LC niches express high levels of bone morphogenetic protein 7 (BMP7) and that Bmp7-deficient mice exhibit substantially diminished LC numbers, with the remaining cells appearing less dendritic. BMP7 induces LC differentiation and proliferation by activating the BMP type-I receptor ALK3 in the absence of canonical TGF-β1–ALK5 signaling. Conversely, TGF-β1–induced in vitro LC differentiation is mediated via ALK3; however, co-induction of ALK5 diminished TGF-β1–driven LC generation. Therefore, selective ALK3 signaling by BMP7 promotes high LC yields. Within epidermis, BMP7 shows an inverse expression pattern relative to TGF-β1, the latter induced in suprabasal layers and up-regulated in outer layers. We observed that TGF-β1 inhibits microbial activation of BMP7-generated LCs. Therefore, TGF-β1 in suprabasal/outer epidermal layers might inhibit LC activation, resulting in LC network maintenance.

28 October 2013 in European Journal of Immunology
Verified
Journal Article
Open access
PDF file
SKSabine Konradi
Sabine Konradi
NYNighat Yasmin
Nighat Yasmin
DHDenise Haslwanter
Denise Haslwanter
MWMichele Weber
Michele Weber
BGBernhard Gesslbauer
Bernhard Gesslbauer
HSHerbert Strobl
Herbert Strobl
Langerhans cells (LCs) are a unique subset of dendritic cells (DCs) that express epithelial adhesion molecules, allowing them to form contacts with epithelial cells and reside in epidermal/epithelial tissues. The dynamic regulation of epithelial adhesion plays a decisive role in the life cycle of LCs. It controls whether LCs remain immature and sessile within the epidermis or mature and egress to initiate immune responses. So far, the molecular machinery regulating epithelial adhesion molecules during LC maturation remains elusive. Here, we generated pure populations of immature human LCs in vitro to systematically probe for gene‐expression changes during LC maturation. LCs down‐regulate a set of epithelial genes including E‐cadherin, while they upregulate the mesenchymal marker N‐cadherin known to facilitate cell migration. In addition, N‐cadherin is constitutively expressed by monocyte‐derived DCs known to exhibit characteristics of both inflammatory‐type and interstitial/dermal DCs. Moreover, the transcription factors ZEB1 and ZEB2 (ZEB is zinc‐finger E‐box‐binding homeobox) are upregulated in migratory LCs. ZEB1 and ZEB2 have been shown to induce epithelial‐to‐mesenchymal transition (EMT) and invasive behavior in cancer cells undergoing metastasis. Our results provide the first hint that the molecular EMT machinery might facilitate LC mobilization. Moreover, our study suggests that N‐cadherin plays a role during DC migration.

1 May 2021 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Open access
TSTommaso Sconocchia
Tommaso Sconocchia
MHMathias Hochgerner
Mathias Hochgerner
ESElke Schwarzenberger
Elke Schwarzenberger
CTCarmen Tam-Amersdorfer
Carmen Tam-Amersdorfer
IBIzabela Borek
Izabela Borek
HSHerbert Strobl
Herbert Strobl
Bone morphogenetic proteins (BMPs) are members of the TGF-β family that signal via the BMP receptor (BMPR) signaling cascade, distinct from canonical TGF-β signaling. BMP downstream signaling is strongly induced within epidermal keratinocytes in cutaneous psoriatic lesions, and BMP7 instructs monocytic cells to acquire characteristics of psoriasis-associated Langerhans dendritic cells (DCs). Regulatory T (Treg)-cell numbers strongly increase during psoriatic skin inflammation and were recently shown to limit psoriatic skin inflammation. However, the factors mediating Treg-cell accumulation in psoriatic skin currently remain unknown. We sought to investigate the role of BMP signaling in Treg-cell accumulation in psoriasis. The following methods were used: immunohistology of patients and healthy controls; ex vivo models of Treg-cell generation in the presence or absence of Langerhans cells; analysis of BMP versus canonical TGF-β signaling in DCs and Treg cells; and modeling of psoriatic skin inflammation in mice lacking the BMPR type 1a in CD11c+ cells. We here demonstrated a positive correlation between Treg-cell numbers and epidermal BMP7 expression in cutaneous psoriatic lesions and show that unlike Treg cells from healthy skin, a portion of inflammation-associated Treg cells exhibit constitutive-active BMP signaling. We further found that BMPR signaling licenses inflammation-associated Langerhans cell/DC to gain an enhanced capacity to promote Treg cells via BMPR-mediated CD25 induction and that this effect is associated with reduced skin inflammation. Psoriatic lesions are marked by constitutive high BMP7/BMPR signaling in keratinocytes, which instructs inflammatory DCs to gain enhanced Treg-cell-stimulatory activity. Locally secreted BMP7 can directly promote Treg-cell generation through the BMP signaling cascade.

1 June 2017 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Open access
JJJennifer Jurkin
Jennifer Jurkin
CKCorinna Krump
Corinna Krump
Rene KoeffelRene Koeffel
Rene Koeffel
CFChristina Fieber
Christina Fieber
CSChristopher Schuster
Christopher Schuster
HSHerbert Strobl
Herbert Strobl
Langerhans cell (LC) networks play key roles in immunity and tolerance at body surfaces. LCs are established prenatally and can be replenished from blood monocytes. Unlike skin-resident dermal DCs (dDCs)/interstitial-type DCs and inflammatory dendritic epidermal cells appearing in dermatitis/eczema lesions, LCs lack key monocyte-affiliated markers. Inversely, LCs express various epithelial genes critical for their long-term peripheral tissue residency. Dendritic cells (DCs) are functionally involved in inflammatory diseases; however, the mechanisms remained poorly understood. In vitro differentiation models of human DCs, gene profiling, gene transduction, and immunohistology were used to identify molecules involved in DC subset specification. Here we identified the monocyte/macrophage lineage identity transcription factor Kruppel-like factor 4 (KLF4) to be inhibited during LC differentiation from human blood monocytes. Conversely, KLF4 is maintained or induced during dermal DC and monocyte-derived dendritic cell/inflammatory dendritic epidermal cell differentiation. We showed that in monocytic cells KLF4 has to be repressed to allow their differentiation into LCs. Moreover, respective KLF4 levels in DC subsets positively correlate with proinflammatory characteristics. We identified epithelial Notch signaling to repress KLF4 in monocytes undergoing LC commitment. Loss of KLF4 in monocytes transcriptionally derepresses Runt-related transcription factor 3 in response to TGF-β1, thereby allowing LC differentiation marked by a low cytokine expression profile. Monocyte differentiation into LCs depends on activation of Notch signaling and the concomitant loss of KLF4.

29 April 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
HTHimadri Bahadur Thapa
Himadri Bahadur Thapa
CPChristina A. Passegger
Christina A. Passegger
DFDominik Fleischhacker
Dominik Fleischhacker
PKPaul Kohl
Paul Kohl
YCYi-Chi Chen
Yi-Chi Chen
SSStefan Schild
Stefan Schild
The gut microbiome contributes to chronic inflammatory responses in ulcerative colitis (UC), but molecular mechanisms and disease-relevant effectors remain unclear. Here we analyze the pro-inflammatory properties of colonic fluid obtained during colonoscopy from UC and control patients. In patients with UC, we find that the pelletable effector fraction is composed mostly of bacterial extracellular vesicles (BEVs) that exhibit high IgA-levels and incite strong pro-inflammatory responses in IgA receptor-positive (CD89+) immune cells. Biopsy analyses reveal higher infiltration of CD89+ immune cells in the colonic mucosa from patients with UC than control individuals. Further studies show that IgA-coated BEVs, but not host-derived vesicles nor soluble IgA, are potent activators of pro-inflammatory responses in CD89+ cells. IgA-coated BEVs also exacerbate intestinal inflammation in a dextran sodium sulfate colitis model using transgenic mice expressing human CD89. Our data thus implicate a link between IgA-coated BEVs and intestinal inflammation via CD89+ immune cells, and also hint a potential new therapeutic target for UC.

1 March 2020 in Cell Reports
Verified
Journal Article
Open access
CLClarice X. Lim
Clarice X. Lim
BLBernett Lee
Bernett Lee
OGOlivia Geiger
Olivia Geiger
CPChristina Passegger
Christina Passegger
MBMichaela Beitzinger
Michaela Beitzinger
HSHerbert Strobl
Herbert Strobl
DC-SIGN+ monocyte-derived dendritic cells (mo-DCs) play important roles in bacterial infections and inflammatory diseases, but the factors regulating their differentiation and proinflammatory status remain poorly defined. Here, we identify a microRNA, miR-181a, and a molecular mechanism that simultaneously regulate the acquisition of DC-SIGN expression and the activation state of DC-SIGN+ mo-DCs. Specifically, we show that miR-181a promotes DC-SIGN expression during terminal mo-DC differentiation and limits its sensitivity and responsiveness to TLR triggering and CD40 ligation. Mechanistically, miR-181a sustains ERK-MAPK signaling in mo-DCs, thereby enabling the maintenance of high levels of DC-SIGN and a high activation threshold. Low miR-181a levels during mo-DC differentiation, induced by inflammatory signals, do not support the high phospho-ERK signal transduction required for DC-SIGNhi mo-DCs and lead to development of proinflammatory DC-SIGNlo/- mo-DCs. Collectively, our study demonstrates that high DC-SIGN expression levels and a high activation threshold in mo-DCs are linked and simultaneously maintained by miR-181a.